Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacologic Control of CAR T Cells.
Caulier B, Enserink JM, Wälchli S. Caulier B, et al. Among authors: walchli s. Int J Mol Sci. 2021 Apr 21;22(9):4320. doi: 10.3390/ijms22094320. Int J Mol Sci. 2021. PMID: 33919245 Free PMC article. Review.
Treating osteosarcoma with CAR T cells.
Köksal H, Müller E, Inderberg EM, Bruland Ø, Wälchli S. Köksal H, et al. Among authors: walchli s. Scand J Immunol. 2019 Mar;89(3):e12741. doi: 10.1111/sji.12741. Epub 2019 Jan 15. Scand J Immunol. 2019. PMID: 30549299 Free article. Review.
A Spheroid Killing Assay by CAR T Cells.
Dillard P, Köksal H, Inderberg EM, Wälchli S. Dillard P, et al. Among authors: walchli s. J Vis Exp. 2018 Dec 12;(142). doi: 10.3791/58785. J Vis Exp. 2018. PMID: 30596389
Long-term surviving cancer patients as a source of therapeutic TCR.
Inderberg EM, Wälchli S. Inderberg EM, et al. Among authors: walchli s. Cancer Immunol Immunother. 2020 May;69(5):859-865. doi: 10.1007/s00262-019-02468-9. Epub 2020 Jan 8. Cancer Immunol Immunother. 2020. PMID: 31915853 Free PMC article. Review.
Colorectal cysts as a validating tool for CAR therapy.
Dillard P, Lie M, Baken E, Lobert VH, Benard E, Köksal H, Inderberg EM, Wälchli S. Dillard P, et al. Among authors: walchli s. BMC Biotechnol. 2020 Jun 1;20(1):30. doi: 10.1186/s12896-020-00623-0. BMC Biotechnol. 2020. PMID: 32487146 Free PMC article.
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy.
Dillard P, Köksal H, Maggadottir SM, Winge-Main A, Pollmann S, Menard M, Myhre MR, Mælandsmo GM, Flørenes VA, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM. Dillard P, et al. Among authors: walchli s. Mol Ther. 2021 Mar 3;29(3):1199-1213. doi: 10.1016/j.ymthe.2020.11.019. Epub 2020 Nov 17. Mol Ther. 2021. PMID: 33212301 Free PMC article.
92 results